| Clarient to Present at Three Investor Conferences in June (PR Newswire) Clarient, Inc. , a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that the company is scheduled to make investor presentations at three investor conferences in the month of June. us.rd.yahoo.com |
Affymax: Long-Term Value Far From Anemic Robert Weinstein submits:Affymax Inc. (AFFY) traded 16 million shares on June 21st, which in itself is not that many for any given stock, but when the whole float is about 20 million shares that is a lot of shares being traded back and forth. Can anyone say HFT (high frequency trading)... ?Complete Story » seekingalpha.com |
Study: Surgery May Reduce Diabetics' Need for Drugs The majority of people with diabetes who had bariatric surgery to lose weight were able to stop taking their diabetes medications, which led to a significant decline in health-care costs. online.wsj.com |
Good Signs Abound for Forest's New Antibiotic EP Vantage submits:Forest Laboratories’ (FRX) ceftaroline received a surprisingly unanimous backing Tuesday from an FDA advisory committee, boding well for final approval from the FDA. The relatively smooth passage also suggests that concerns that the antibiotic might be tripped up by the ongoing debate around the evaluation of such products in the US were overstated. As such, after a pretty torrid time for antibiotic approvals in the US, other companies approaching the FDA with late stage antibiotics could well be taking comfort from ceftaroline’s progress so far.Complete Story » seekingalpha.com |
Glaxo to Build New Plant in U.K. GlaxoSmithKline said it will build its first new manufacturing capacity in Britain in about 25 years in response to the U.K. government's plan to cut the rate of corporation tax on income from patents. online.wsj.com |